Spots Global Cancer Trial Database for A Study of BMS-986406 as Monotherapy and Combination Therapies in Participants With Advanced Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of BMS-986406 as Monotherapy and Combination Therapies in Participants With Advanced Tumors
Official Title: A Phase 1 First-in-human Study of BMS-986406 as Monotherapy and Combination Therapies in Participants With Advanced Malignant Tumors
Study ID: NCT05298592
Conditions
Study Description
Brief Summary: The purpose of this study is to assess the safety and tolerability of BMS-986406 administered alone, in combination with nivolumab, or in combination with nivolumab and platinum-doublet chemotherapy (PDCT) in participants with advanced tumors.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Local Institution - 0021, Birmingham, Alabama, United States
University California San Diego Moores Cancer Center, La Jolla, California, United States
The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate, Los Angeles, California, United States
UCLA Health, Los Angeles, California, United States
Yale Cancer Center, New Haven, Connecticut, United States
Local Institution - 0001, Hackensack, New Jersey, United States
Carolina BioOncology Institute, PLLC, Huntersville, North Carolina, United States
Sanford Cancer Center, Sioux Falls, South Dakota, United States
Mary Crowley Cancer Research - Medical City Hospital, Dallas, Texas, United States
VCU Massey Cancer Center, Richmond, Virginia, United States
Local Institution - 0029, Viedma, Rio Negro, Argentina
Local Institution - 0023, Rosario, Santa Fe, Argentina
Local Institution - 0028, Buenos Aires, , Argentina
Local Institution - 0032, Cordoba, , Argentina
Local Institution - 0018, Brussel (Jette), Brussel, Belgium
Local Institution - 0015, Edegem, MA, Belgium
Local Institution - 0012, Brussels, , Belgium
Local Institution - 0031, Kashiwa-shi, Chiba, Japan
Local Institution - 0026, Seongnam, Gyeonggi-do, Korea, Republic of
Local Institution - 0024, Seoul, , Korea, Republic of
Local Institution - 0027, Seoul, , Korea, Republic of
Local Institution - 0025, Seoul, , Korea, Republic of
Local Institution - 0008, Malaga, Andaluca, Spain
Local Institution - 0022, Barcelona, , Spain
Local Institution - 0030, Barcelona, , Spain
Hospital Universitario Vall dHebron, Barcelona, , Spain
Institut Catala dOncologia ICO - Hospital Duran i Reynals Location, Barcelona, , Spain
Local Institution - 0014, Madrid, , Spain
Local Institution - 0009, Madrid, , Spain
Local Institution - 0016, Madrid, , Spain
Local Institution - 0033, Pamplona, , Spain
Contact Details
Name: Bristol-Myers Squibb
Affiliation: Bristol-Myers Squibb
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
